1 / 22

When Using DOPPS Slides

When Using DOPPS Slides. DOPPS Slide Use Guidelines. Greater first-year survival on hemodialysis in facilities in which patients are provided earlier and more frequent pre-nephrology visits. Introduction. DOPPS Background (1). DOPPS Background (2). Methods.

vina
Télécharger la présentation

When Using DOPPS Slides

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. When Using DOPPS Slides

  2. DOPPS Slide Use Guidelines

  3. Greater first-year survival on hemodialysis in facilities in which patients are provided earlier and more frequent pre-nephrology visits

  4. Introduction

  5. DOPPS Background (1)

  6. DOPPS Background (2)

  7. Methods

  8. Table 1: Patient Characteristics by PNVa (1)

  9. Table 1: Patient Characteristics by PNV (2)

  10. Table 1: Patient Characteristics by PNV (3)

  11. Figure 1: Percentage of PNV by Country

  12. Figure 2: Distribution of Mean Facility %PNV

  13. Table 2: Adjusted Odds Ratio of PNVa (1)

  14. Table 2: Adjusted Odds Ratio of PNV (2)

  15. Table 2: Adjusted Odds Ratio of PNV (3)

  16. Table 2: Adjusted Odds Ratio of PNV (4)

  17. Figure 3: Cumulative Hazard of All-Cause Mortality by PNV

  18. Figure 4: Lower Risk for All-Cause Mortality by Greater Mean Facility %PNV

  19. Figure 5: Lower Risk of All-Cause Mortality for Patients who Saw a Nephrologist More Often in the Year Before Starting Hemodialysis

  20. Table 3: Adjusted Hazard Ratio for All-Cause Mortality by Facility Prevalence of PNVa

  21. Conclusions

  22. Acknowledgements

More Related